¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mortality rate curve"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • curve
    °î¼±
  • calibration curve
    ±³Á¤°î¼±, Ç¥ÁØÈ­°î¼±
  • demand curve
    ¼ö¿ä°î¼±
  • depth dose curve
    ½ÉºÎ¼±·®°î¼±
  • dissociation curve
    ÇØ¸®°î¼±
  • distribution curve
    ºÐÆ÷°î¼±
  • dose-response curve
    ¿ë·®¹ÝÀÀ°î¼±
  • extension curve
    ½ÅÀü°î¼±
  • elastic curve
    ź·Â°î¼±
  • epidemic curve
    À¯Çà°î¼±
  • equal loudness curve
    À½·®µî°¨°î¼±
  • equilibrium curve
    ÆòÇü°î¼±
  • flow volume curve
    À¯·®¿ë·®°î¼±
  • fluid velocity curve
    À¯¼Ó°î¼±
  • frequency curve
    µµ¼ö°î¼±
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • fetal heart rate
    žƽɹڼö
  • five-year survival rate
    ¿À³â»ýÁ¸·ü
  • glomerular filtration rate
    Å丮¿©°úÀ², »ç±¸Ã¼¿©°úÀ²
  • heart rate
    ½ÉÀå¹Úµ¿¼ö
  • morbidity rate
    ÀÌȯ·ü
  • mutation rate
    µ¹¿¬º¯ÀÌÀ²
  • onset rate
    ¹ß»ý·ü
  • peak expiratory flow rate
    ÃÖ°í³¯¼û¼Óµµ, ÃÖ°íÈ£±âÀ¯¼Ó
  • perfusion rate
    °ü·ù¼Óµµ, °ü·ùÀ²
  • pregnancy rate
    Àӽŷü
  • prevalence rate
    À¯º´·ü
  • pulse rate
    ¸Æ¹Ú¼ö
  • relaxation rate
    À̿Ϸü
  • respiratory rate
    È£Èí¼öÈ£Èí·ü
  • response rate
    ¹ÝÀÀ·ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • bone conduction curve
    »ÀÀüµµÃ»·Â°î¼±, °ñµµÃ»·Â°î¼±
  • curve
    °î¼±
  • calibration curve
    ±³Á¤°î¼±, Ç¥ÁØÈ­°î¼±
  • cardiac function curve
    ½ÉÀå±â´É°î¼±
  • concentration-response curve
    ³óµµ¹ÝÀÀ°î¼±
  • concentration-time curve
    Ç÷Áß³óµµ°î¼±
  • demand curve
    ¼ö¿ä°î¼±
  • depth dose curve
    ½ÉºÎ¼±·®°î¼±
  • dissociation curve
    ÇØ¸®°î¼±
  • distribution curve
    ºÐÆ÷°î¼±
  • dose-response curve
    ¿ë·®¹ÝÀÀ°î¼±
  • elastic curve
    ź·Â°î¼±
  • epidemic curve
    À¯Çà°î¼±
  • equal loudness curve
    À½·®µî°¨°î¼±
  • equilibrium curve
    ÆòÇü°î¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Heart rate
    ½É¹Ú¼ö(ãýÚÑâ¦)
  • MVR=£¾maximus voiding rate
    ÃÖ´ë¹è´¢À².
  • Westergren sedimentation rate
    ¿þ½ºÅͱ׷»Ä§°­¼Óµµ
  • absorbed dose rate
    Èí¼ö¼±·®À²
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü(ËàÌ¡Ë×ËÎËô).
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü.
  • age specific death rate
    ¿¬·Éº° »ç¸Á·ü
  • air kerma-rate constant
    °ø±âÄ¿¸¶À²»ó¼ö
  • alveolar ventilation rate
    ÆóÆ÷ȯ±âºñ(¡­üµÑ¨Ýï)
  • arterial perfusion rate
    µ¿¸Æ°ü·ùÀ²
  • fractional fibrinogen catabolic rate
    ºÐȹº° ¼¶À¯¼Ò¿ø ´ë»çÀ².
  • frame rate
    È­¸éÀ²
  • frame rate
    È­¸é ¹ß»ýÀ² (ûþØü Û¡ßæëÒ)
  • general fertility rate
    ÀϹÝÃâ»êÀ².
  • general fertility rate
    ÀϹÝÃâ»êÀ².
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • proportional mortality indicator
    ºÎºÐºñ»ç¸ÁÁö¼ö.
  • proportionate mortality
    »ç¸Áºñ(Ë×ËÎËÓ).
  • air conduction curve
    ±âµµÃ»·Â°î¼±
  • area under the concentration-time curve : AUC
    Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
  • articulation curve
    (¾ð¾î)¸í·áµµ°î¼±
  • audiometric curve
    û·Â°î¼±(ôéæ³ÍØàÊ)
  • auditory sensation curve
    °¡Ã»°î¼±
  • bacterial growth curve
    ¼¼±ÕÁõ½Ä°î¼±
  • base curve
    ±âº»°î¼±(Ë»ËÓË­ËÛ).
  • base curve
    ±âº»¸¸°î(µµ)
  • bimodal curve
    ÀÌ Á¤Á¡(Ì¡Ëø)°î¼±.
  • binomial curve
    ÀÌÇ×°î¼±(ÊÙË­ËÛ).
  • boiling curve
    ºñµî°î¼±(¡­ÍØàÊ).
  • bone conduction curve
    °ñµµÃ»·Â°î¼±
  • calibration curve
    ±³Á¤°î¼±
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • polarization curve
    Æí±Ø°î¼±(ø¶Ð¿ÍØàÊ)
  • precipitin curve
    ħ°­¼Ò(öØË½áÈ) °î¼±(ÍØàÊ)
  • probability curve
    È®·ü °î¼±(ü¬×ËÍØàÊ)
  • progress curve
    ÁøÇà°î¼±(òäú¼ÍØàÊ)
  • quench correction curve
    ¼Ò±¤ ±³Á¤°î¼±(á¼ÎÃÎìïáÍØàÊ).
  • regression curve
    ȸ±Í°î¼±(üÞÏýÍØàÊ)
  • saturation curve
    Æ÷È­ °î¼±(øéûùÍØàÊ)
  • solubility curve
    ¿ëÇØµµ °î¼±(éÁú°ÓøÍØàÊ)
  • S-shaped curve
    SÀÚ(í®)Çü(úþ) °î¼±(ÍØàÊ)
  • standard curve
    Ç¥Áذ(øöñÞÍØàÊ)
  • survival curve
    »ýÁ¸°î¼± (ßæðíÍØàÊ)
  • titration curve
    ÀûÁ¤ °î¼± (îÙïÒÍØàÊ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CMR cardiomodulorespirography; cerebral metabolic rate; chief medical resident; common medical record; c...
NMR neonatal mortality rate; nictitating membrane response; nuclear magnetic resonance
RSMR relative standard mortality rate
SMR senior medical resident; sensorimotor rhythm; severe mental retardation; sexual maturity rating; ske...
SPMR standard proportionate mortality ratio (or rate)
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AUC Area under the concentration curve
AUC Area-under-the-response-curve
AUC Areas under the ROC curve
CRC concentration response curve
FTC frequency tuning curve
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • normal curve
    Á¤»ó °î¼±, Á¤±Ô °î¼±
  • occlusal curve
    ±³ÇÕ ¸¸°î
    ±³ÇÕ¸éÀÌ ³õÀÌ°Ô µÇ´Â ÀüµÎ¸é°ú ½Ã»ó¸é »óÀÇ Ä¡¿­ÀÇ ¸¸°î.
  • orientation plate for lateral compensating curve
    Ãø¹æ ¸¸°î ±âÁØÆÇ
    ÃÑ ÀÇÄ¡ÀÇ ÀΰøÄ¡ ¹è¿­ÀÇ °æ¿ì ±³Çձ⠻󿡼­ Àû´çÇÑ Á¶Àý ¸¸°îÀ» ÁÙ ¶§ »ç¿ëÇÏ´Â ±âÁØÆÇ. MonsonÀº Á¶Àý ¸¸°îÀÇ ¹Ý°æÀ» 10§¯·Î Çϰí ÀÖ´Ù. ¾ç ÁßÀýÄ¡¿Í Á¦ 2´ë±¸Ä¡ ¿ø½É ÇùÃø ±³µÎ¸¸À» ±³ÇÕÁ¦»ó¸é¿¡ Á¢Ã˽Ã۰í
  • oxygen dissociation curve
    »ê¼Ò ÇØ¸® °î¼±
  • oxygen saturaon curve
    »ê¼Ò Æ÷È­ °î¼±
  • oxyhemoglobin dissociation curve
    »êÈ­ Çì¸ð±Û·Îºó ÇØ¸® °î¼±
  • phase curve
    À§»ó °î¼±
  • quadratic curve
    ÀÌÂ÷ °î¼±
  • regression curve
    ȸ±Í °î¼±
  • sagittal curve of occlusion
    ±³ÇÕÀÇ ½Ã»ó ¸¸°î
  • sagittal occlusal curve
    ÀüÈÄ ±³ÇÕ ¸¸°î
    ÀÚ¿¬ Ä¡¿­¿¡¼­, °¢ Ä¡¾Æ´Â ÀüÈÄ ¹× Ãø¹æ¿¡ ¸¸°îÀ» º¸ÀÌ¸ç ¹è¿­ÇØ Àִµ¥ ±× Áß¿¡¼­ ½Ã»ó¸é»óÀ¸·Î º» »ó¾Ç Ä¡¾ÆÀÇ ±³µÎÁ¤À» ¿¬°áÇÑ °î¼±À» ¸»ÇÑ´Ù.
  • Scammon curve
    ½ºÄɸó °î¼±
  • tension-length curve
    Àå·Â ±æÀÌ °î¼±
  • tension-length diagram curve
    Àå·ÂÀåµµ °î¼±
  • toxic effect curve
    µ¶¼º °î¼±
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
gaussian curve Continuous frequency distribution of infinite range. Its properties are as follows: 1) continuous, symmetrical distribution with both tails extending to infinity; 2) arithmetic mean, mode, and median identical; and 3) shape completely determined by the mean and standard deviation.
(12 Dec 1998)
receiver operating characteristic curve A plot of true positive versus false positive results, usually in a trial of a diagnostic test.
A graphical means of assessing the ability of a screening test to discriminate between healthy and diseased persons.
Synonym: ROC curve.
(05 Mar 2000)
Carus' curve An imaginary curved line obtained from a mathematical formula, supposed to indicate the outlet of the pelvic canal.
Synonym: Carus' circle.
(05 Mar 2000)
maximal expiratory flow-volume curve <chest medicine> Curves depicting maximal expiratory flow in liters/second at each point of lung inflation (expressed in liters or percentage of forced vital capacity) during a forced vital capacity determination. Common abbreviation is mefv.
(12 Dec 1998)
passive length-tension curve The relationship between passive tension and preload (rest length) for a muscle at rest.
(05 Mar 2000)
von Spee's curve The anatomic curvature of the mandibular occlusal plane beginning at the tip of the lower cuspid and following the buccal cusps of the posterior teeth, continuing to the terminal molar.
Synonym: von Spee's curve.
(05 Mar 2000)
reverse curve In dentistry, a curve of occlusion which is convex upward.
Synonym: anti-Monson curve.
(05 Mar 2000)
characteristic curve Sensitometric curve of radiographic film, a plot of the film density versus the logarithm of the relative exposure.
Synonym: H and D curve, Hunter and Driffield curve.
(05 Mar 2000)
growth curve A graphic representation of the change in size of an individual or a population over a period of time.
(05 Mar 2000)
roc curve A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli.
(12 Dec 1998)
Monson curve The curve of occlusion in which each cusp and incisal edge touches or conforms to a segment of the surface of a sphere 8 inches in diameter with its centre in the region of the glabella.
(05 Mar 2000)
compensating curve The anteroposterior and lateral curvature in the alignment of the occluding surfaces and incisal edges of artificial teeth; used to develop balanced occlusion.
(05 Mar 2000)
whole-body titration curve A graphic representation of the in vivo changes in hydrogen ion, PaCO2, and bicarbonate which occur in arterial blood in response to primary acid-base disturbances.
(05 Mar 2000)
concentration-effect curve <pharmacology> This is a graph produced to show the relationship between the exposure concentration of a drug or other foreign chemical and the magnitude of the graded effect that it produces.
(05 Jan 1998)
concentration-response curve <pharmacology> This is a graph produced to show the relation between the exposure concentration of a drug (or other chemical) and the degree of response it produces, as measured by the percentage of the exposed population showing a defined, often quantal, effect.
(05 Jan 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • death rate
    »ç¸Á·ü(mortality)
  • differential rate
    (öµµ µîÀÇ)ƯÁ¤ ¿îÀÓ·ü
  • discount rate
    ¾îÀ½ ÇÒÀÎÀ²;ÀçÇÒÀÎÀ²
  • economic growth rate
    °æÁ¦ ¼ºÀå·ü 9
  • effective exchange rate
    (±ÝÀ¶)½ÇÈ¿ ȯ½Ã¼¼(ȯÀ²)(±¹Á¦ÅëÈ­±â±ÝÀÌ ´çÇØ±¹°ú ´Ù¸¥ ÁÖ¿ä 20°³±¹ ÅëÈ­ÀÇ È¯½Ã¼¼¸¦ º¹ÇÕ½ÃÄÑ »êÃâÇÏ´Â Áö¼ö)
  • exchange rate
    ȯÀ²
  • fatality rate
    »ç¸Á·ü
  • fixed exchange rate(system)
    °íÁ¤È¯½Ã¼¼(Á¦)
  • flat rate
    °íÁ¤(Á¤¾×)¿ä±Ý
  • floating exchange rate system
    º¯µ¿ ȯÀ²Á¦
  • floating rate
    ÀÚÀ¯ º¯µ¿ ½Ã¼¼;¼±Çϼ¼
  • forward rate
    (¿Ü±¹È¯ÀÇ) ¼±¹° ½Ã¼¼
  • freight rate
    ¿îÀÓ·ü Àå
  • fuel rate
    Ãʰ£ ¿¬·á ¼ÒºñÀ²
  • interest rate
    ±Ý¸®ÀÌÀ²
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á